Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001214659-21-002113
Filing Date
2021-02-19
Accepted
2021-02-19 16:05:16
Documents
2
Period of Report
2021-02-10

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT marketforms-51512.html 3  
1 PRIMARY DOCUMENT marketforms-51512.xml 3 1707
2 POA DOCUMENT poa.htm EX-24 2969
  Complete submission text file 0001214659-21-002113.txt   6119
Mailing Address 30 TECHNOLOGY DRIVE WARREN NJ 07059
Business Address 30 TECHNOLOGY DRIVE WARREN NJ 07059 908-941-1900
Aquestive Therapeutics, Inc. (Issuer) CIK: 0001398733 (see all company filings)

EIN.: 208623253 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O AMAG PHARMACEUTICALS, INC. 1100 WINTER STREET WALTHAM MA 02451
Business Address
Krop Julie (Reporting) CIK: 0001643127 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38599 | Film No.: 21655581